Read Incubate’s blog on the recently announced March-In proposal.
Incubate advocates for the patient, corporate, and investment communities by educating policymakers on the role of venture capital in bringing promising, innovative treatments to patients in need.
What We Do
Help ensure a level global playing field for investment and promote policies that empower life science innovators to build and grow in the United States.
Strengthen and protect U.S. intellectual property provisions by promoting patent and regulatory systems that encourage life sciences innovation.
Amplify the results
Spotlight the venture capital-driven breakthroughs that are transforming medicine for patients and health professionals around the globe.
Incubate is an international coalition of life science venture capitalists committed to educating
policymakers on the role of venture capital in bringing promising, innovative treatments to patients in
This bipartisan legislation would eliminate the small-molecule penalty by aligning the price-setting timeline for small and large molecule medicines.
Stories from the Early-Stage Life Sciences Ecosystem
Listen to industry experts delve into the process behind scientific breakthroughs (and how many of them almost never happened), where the life science ecosystem is taking us next, and most importantly, what it means for patients.